Company intelligence / Profile preview

Diabetes Zentrum Mergentheim

Bad Mergentheim, Baden-Württemberg, Germanydiabetes-zentrum.de ↗

Ownership: Private
Development stage: Other

Overview

Diabetes Zentrum Mergentheim is one of Germany’s leading specialist centers for the treatment and management of diabetes mellitus. It provides comprehensive inpatient and outpatient care to thousands annually—including complex cases—and conducts clinical trials through its FIDAM institute. The center is recognized for its expertise in treating complicated diabetic conditions and developing patient education programs. It also collaborates internationally to advance standards in diabetes care.

Therapeutic areas: Endocrinology
Modalities: Hormone therapyDevice-based therapy
Industry: Academic Hospital/University/Research

Partnerships

United Eastern Medical Services/UEMedical HealthPlus Abu Dhabi partnership for international knowledge transfer

Beyond the preview

Go deeper on Diabetes Zentrum Mergentheim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diabetes Zentrum Mergentheim.

Explore the full profile